Rizatriptan benzoate
NDC 62135-998, Rizatriptan Benzoate, tablet, orally disintegrating, from Chartwell RX, LLC.
- Product NDC
- 62135-998
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078739
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-998 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RIZATRIPTAN BENZOATE5 mg/1
Pharmacologic classes
Serotonin 1b Receptor Agonists [MoA]; Serotonin 1d Receptor Agonists [MoA]; Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-998-17 | 62135099817 | 18 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62135-998-17) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/faf3bc1d-8818-47b0-8ad1-80bfbf40ab78
Use it
Look up 62135-998 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-998 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-998. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.